Skip to main content
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1988 Jul;26(1):110–112. doi: 10.1111/j.1365-2125.1988.tb03374.x

LTD4-induced bronchoconstriction in patients with asthma: lack of a vagal reflex.

L E Ayala 1, N B Choudry 1, R W Fuller 1
PMCID: PMC1386510  PMID: 2849473

Abstract

The mechanism by which leukotriene D4 (LTD4) induces bronchoconstriction in man is unclear. We have investigated this mechanism by examining the effect of nedocromil sodium and ipratropium bromide on LTD4-induced bronchoconstriction in six mild asthmatic patients. The bronchoconstrictor response to increasing concentrations of inhaled LTD4 (0.08 to 100 nmol) was assessed by measuring changes in respiratory resistance (Rrs) at 6 Hz by the forced oscillation method. Results were expressed as the provocative dose causing 100% increase in Rrs (PD100). Neither nedocromil (4 mg) nor ipratropium (0.8 mg) showed significant effect on LTD4-induced bronchoconstriction in asthmatic subjects. These results suggest that in asthmatics LTD4-induced bronchoconstriction is unlikely to involve vagal reflexes.

Full text

PDF
110

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Advenier C., Cerrina J., Duroux P., Floch A., Pradel J., Renier A. Sodium cromoglycate, verapamil and nicardipine antagonism to leukotriene D4 bronchoconstriction. Br J Pharmacol. 1983 Feb;78(2):301–306. doi: 10.1111/j.1476-5381.1983.tb09395.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Barnes N. C., Piper P. J., Costello J. F. Comparative effects of inhaled leukotriene C4, leukotriene D4, and histamine in normal human subjects. Thorax. 1984 Jul;39(7):500–504. doi: 10.1136/thx.39.7.500. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bisgaard H., Groth S. Bronchial effects of leukotriene D4 inhalation in normal human lung. Clin Sci (Lond) 1987 May;72(5):585–592. doi: 10.1042/cs0720585. [DOI] [PubMed] [Google Scholar]
  4. Dixon C. M., Fuller R. W., Barnes P. J. Effect of nedocromil sodium on sulphur dioxide induced bronchoconstriction. Thorax. 1987 Jun;42(6):462–465. doi: 10.1136/thx.42.6.462. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Gross M. J. Sch 1000: a new anticholinergic bronchodilator. Am Rev Respir Dis. 1975 Dec;112(6):823–828. doi: 10.1164/arrd.1975.112.6.823. [DOI] [PubMed] [Google Scholar]
  6. König P., Hordvik N. L., Kreutz C. The preventive effect and duration of action of nedocromil sodium and cromolyn sodium on exercise-induced asthma (EIA) in adults. J Allergy Clin Immunol. 1987 Jan;79(1):64–68. doi: 10.1016/s0091-6749(87)80018-0. [DOI] [PubMed] [Google Scholar]
  7. Lándsér F. J., Nagles J., Demedts M., Billiet L., van de Woestijne K. P. A new method to determine frequency characteristics of the respiratory system. J Appl Physiol. 1976 Jul;41(1):101–106. doi: 10.1152/jappl.1976.41.1.101. [DOI] [PubMed] [Google Scholar]
  8. Roberts J. A., Giembycz M. A., Raeburn D., Rodger I. W., Thomson N. C. In vitro and in vivo effect of verapamil on human airway responsiveness to leukotriene D4. Thorax. 1986 Jan;41(1):12–16. doi: 10.1136/thx.41.1.12. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Roberts J. A., Rodger I. W., Thomson N. C. Effect of verapamil and sodium cromoglycate on leukotriene D4 induced bronchoconstriction in patients with asthma. Thorax. 1986 Oct;41(10):753–758. doi: 10.1136/thx.41.10.753. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Stewart A. G., Thompson D. C., Fennessy M. R. Interaction of leukotriene D4 and histamine on bronchomotor tone, in the guinea-pig. J Pharm Pharmacol. 1983 Nov;35(11):755–756. doi: 10.1111/j.2042-7158.1983.tb02887.x. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES